Stereotactic Body Radiotherapy Boost Versus Simultaneous Integrated Boost to Pelvic Nodes Among Patients Receiving Radical Chemoradiation in Carcinoma Cervix

Cervical cancer is a significant cause of morbidity and mortality among women worldwide. Radiotherapy, in combination with chemotherapy or as a standalone treatment, is an effective treatment option for cervical cancer. However, traditional radiotherapy has its limitations, such as the potential for damage to surrounding healthy tissues. Stereotactic Body RadioTherapy (SBRT) is a newer radiotherapy technique that delivers high doses of radiation to the tumor with minimal damage to the surrounding tissues. This study aims to evaluate the safety of Stereotactic Body RadioTherapy to involved node in cervical cancer.

NCT Number	NCT07585929
Lead Sponsor	All India Institute of Medical Sciences
Conditions	Stage IIIC
Enrollment	150 participants
Start Date	2024-11-20
Primary Completion	2025-11-19 (estimated)
Study Completion	2026-11-19 (estimated)
Updated on ClinicalTrials.gov	2026-05-29